Source: BEFREE

Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs401681
rs401681
CUI: C0025202
Disease: melanoma
melanoma
0.860 GeneticVariation BEFREE In a multivariable model that included only the most statistically significant findings from univariable modeling and adjusted for pigmentary phenotype, back nevi, and baseline features, we found TERT/CLPTM1L rs401681 (P = 0.004), TYRP1 rs2733832 (P = 0.006), MTAP rs1335510 (P = 0.0005), TYR rs10830253 (P = 0.003), and MX2 rs45430 (P = 0.008) to be significantly associated with multiple primary melanoma, while NCOA6 rs4911442 approached significance (P = 0.06). 25837821

2015

dbSNP: rs401681
rs401681
CUI: C0025202
Disease: melanoma
melanoma
0.860 GeneticVariation BEFREE In the melanoma dataset, two pancreatic cancer susceptibility variants were associated: NR5A2 (rs12029406; OR, 1.39; 95% CI, 1.01-1.92; P = 0.04) and CLPTM1L-TERT (rs401681; OR, 1.16; 95% CI, 1.01-1.34; P = 0.04). 24642353

2014

dbSNP: rs401681
rs401681
CUI: C0025202
Disease: melanoma
melanoma
0.860 GeneticVariation BEFREE We also obtained significant results when we tested the association between rs401681 variant (TERT-CLPTM1L locus) with melanoma risk (Odds ratio, OR; 95% confidence interval, CI=1.24 (1.08-1.43); p-value, 3×10(-3)). 25457634

2014

dbSNP: rs401681
rs401681
CUI: C0025202
Disease: melanoma
melanoma
0.860 GeneticVariation BEFREE These findings suggested that rs401681 C allele was a low-penetrance risk allele for the development of cancers of lung, bladder, prostate and basal cell carcinoma, but a potential protective allele for melanoma and pancreatic cancer. 23226346

2012

dbSNP: rs401681
rs401681
CUI: C0025202
Disease: melanoma
melanoma
0.860 GeneticVariation BEFREE Also, the SNP rs401681 in the TERT-CLPTM1L locus was replicated for the association with melanoma risk. 21116649

2011

dbSNP: rs401681
rs401681
CUI: C0025202
Disease: melanoma
melanoma
0.860 GeneticVariation BEFREE We evaluated the association between single nucleotide polymorphism (SNP) rs401681 (C > T) and mean telomere length, using quantitative real-time PCR, in blood-extracted DNA collected from 11,314 cancer-free participants from the Sisters in Breast Screening study, the Melanoma and Pigmented Lesions Evaluative Study melanoma family study, and the SEARCH Breast, Colorectal, Melanoma studies. 20570912

2010

dbSNP: rs3219090
rs3219090
CUI: C0025202
Disease: melanoma
melanoma
0.820 GeneticVariation BEFREE We confirmed the proposed role of rs3219090, located on the PARP1 gene, and rs12203592, located on the IRF4 gene, as protective to MM along the same lines as have previous genome-wide associated works. 23537197

2013

dbSNP: rs3219090
rs3219090
CUI: C0025202
Disease: melanoma
melanoma
0.820 GeneticVariation BEFREE We also show evidence suggesting that melanoma associates with 1q42.12 (rs3219090, P = 9.3 × 10(-8)). 21983785

2011

dbSNP: rs45430
rs45430
MX2
CUI: C0025202
Disease: melanoma
melanoma
0.820 GeneticVariation BEFREE A single nucleotide polymorphism (SNP), rs45430, in an intron of the MX2 gene, was previously reported as a novel melanoma susceptibility locus in genome-wide association studies. 31660681

2019

dbSNP: rs45430
rs45430
MX2
CUI: C0025202
Disease: melanoma
melanoma
0.820 GeneticVariation BEFREE In a multivariable model that included only the most statistically significant findings from univariable modeling and adjusted for pigmentary phenotype, back nevi, and baseline features, we found TERT/CLPTM1L rs401681 (P = 0.004), TYRP1 rs2733832 (P = 0.006), MTAP rs1335510 (P = 0.0005), TYR rs10830253 (P = 0.003), and MX2 rs45430 (P = 0.008) to be significantly associated with multiple primary melanoma, while NCOA6 rs4911442 approached significance (P = 0.06). 25837821

2015

dbSNP: rs17119461
rs17119461
CUI: C0025202
Disease: melanoma
melanoma
0.810 GeneticVariation BEFREE In the PanScan data, initial associations were found with melanoma susceptibility variants in NCOA6 [rs4911442; OR, 1.32; 95% confidence interval (CI), 1.03-1.70; P = 0.03], YWHAZP5 (rs17119461; OR, 2.62; 95% CI, 1.08-6.35; P = 0.03), and YWHAZP5 (rs17119490; OR, 2.62; 95% CI, 1.08-6.34; P = 0.03), TYRP1 (P = 0.04), and IFNA13 (P = 0.04). 24642353

2014

dbSNP: rs1801516
rs1801516
ATM
CUI: C0025202
Disease: melanoma
melanoma
0.810 GeneticVariation BEFREE Finally, rs1801516, located on the ATM gene, showed a trend towards a protective role in MM similar to the one firstly described in a GWAS study. 23537197

2013

dbSNP: rs4698934
rs4698934
CUI: C0025202
Disease: melanoma
melanoma
0.810 GeneticVariation BEFREE The SNP rs4698934 was nominally significantly associated with melanoma risk. 24980573

2014

dbSNP: rs7023329
rs7023329
CUI: C0025202
Disease: melanoma
melanoma
0.810 GeneticVariation BEFREE One SNP in MTAP (methylthioadenosine phosphorylase) (rs7023329) that was previously associated with melanoma and nevi in multiple genome-wide association studies was associated with CRC, CA and OS by ASSET (P=0.007). 23361049

2013

dbSNP: rs910873
rs910873
CUI: C0025202
Disease: melanoma
melanoma
0.810 GeneticVariation BEFREE Our results do not support an association between CMM and any of the STX17 SNPs and provide no evidence for interactions between the melanoma risk SNP rs910873 on chromosome 20 and any of the STX17 SNPs. 19209086

2009

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE In two out of six families with both mesothelioma and melanoma we identified either a germline nonsense mutation (c.1153C > T, p.Arg385*) in BAP1 or a recurrent pathogenic germline mutation (c.301G > T, p.Gly101Trp) in CDKN2A. 27181379

2016

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE We found the disease-associated mutations p.R24P (8×), p.N71T (1×), p.G101W (1×), and p.V126D (1×) in the group with affected relatives and p.R24P (2×) in the group with several primary melanomas. 26225579

2015

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE Three of them are CDKN2A mutations previously described in the Mediterranean population (p.G101W, p.V59G and c.358delG) in addition to an undescribed deletion (p. M54del) which has been detected in a melanoma kindred. 20653773

2010

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. 17397031

2007

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 15577313

2004

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE One G101W-positive PC patient with a melanoma in a first-degree relative harbored a germline deletion of the second allele, including exon 1B. 14679123

2004

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE We investigated the frequency of the MC1R variants in the Italian region of Liguria, where the occurrence and penetrance of melanoma are low and primary susceptibility is characterized by prevalence of the CDKN2A c.301G>T [p.G101W] founder mutation. 15221796

2004

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families. 11807902

2002

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE Two p16 germline mutations were identified: G101W, which has been previously observed in a number of melanoma kindreds, and G122V, a novel missense mutation. 10951521

2000

dbSNP: rs104894094
rs104894094
CUI: C0025202
Disease: melanoma
melanoma
0.800 GeneticVariation BEFREE All other variants detected either constitutionally in familial melanoma patients (I49T, R87P, G101W and V126D) or somatically in melanomas (N71S, and P81L), appeared functionally impaired in this assay. 10389768

1999